A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

Haitao Wen; Jenny P.‐Y. Ting; Luke O'neill

doi:10.17615/r6bf-fp90

Related publications

Article2012

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

Haitao Wen, Jenny P.‐Y. Ting, Luke O'neill

Nature Immunology

Article2015

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

Rebecca C. Coll, Avril A. B. Robertson, Jae Jin Chae, Sarah Higgins, Raúl Muñoz-Planillo, Marco Inserra, Irina Vetter, Lara S. Dungan, Brian G. Monks, Andrea Stutz, Daniel E. Croker, Mark S. Butler, Moritz Haneklaus, Caroline E. Sutton, Gabriel Núñez, Eicke Latz, Daniel L. Kastner, Kingston H. G. Mills, Seth L. Masters, Kate Schroder, Matthew A. Cooper, Luke O'neill

Nature Medicine

Article2019

Metabolic Reprogramming of the Cystic Fibrosis Neutrophil Drives Interleukin-1β via the NLRP3 Inflammasome

Oliver J. McElvaney, Zbigniew Zasłona, Eva M. Pålsson‐McDermott, Cedric Gunaratnam, Luke O'neill, Emer P. Reeves, Noel G. McElvaney

Article2017

Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation

Weiqiang Chen, Suan‐Sin Foo, Ali Zaid, Terk‐Shin Teng, Lara J. Herrero, Stefan Wolf, Kothila Tharmarajah, Luan D. Vu, Caryn van Vreden, Adam Taylor, Joseph R. Freitas, Rachel Li, Trent M. Woodruff, Richard D. Gordon, David M. Ojcius, Helder I. Nakaya, Thirumala‐Devi Kanneganti, Luke O'neill, Avril A. B. Robertson, Nicholas J. C. King, Andreas Suhrbier, Matthew A. Cooper, Lisa F. P. Ng,

Article2016

Evidence against a role for NLRP3-driven inflammation in the db/db mouse model of type 2 diabetes

Hélène L. Kammoun, Tamara L. Allen, Darren C. Henstridge, S. Barre, Rebecca C. Coll, Mark S. Butler, A. A. B. Roberston, Luke O'neill, Andrew Murphy, Matthew A. Cooper, Mark A. Febbraio

ResearchOnline at James Cook University (James Cook University)

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

Abstract

Discussion(0)

Related publications

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

Metabolic Reprogramming of the Cystic Fibrosis Neutrophil Drives Interleukin-1β via the NLRP3 Inflammasome

Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation

Evidence against a role for NLRP3-driven inflammation in the db/db mouse model of type 2 diabetes